عاجل اهم الاخبار

Good news about the new Corona Mutant

Good news about the new Corona Mutant

Good news about the new Corona Mutant

According to Reuters, G.S.K. said in a statement that laboratory analyses of its antibody-based anti-Cofid-19 treatment, developed in collaboration with its partner in the United States, FAIR, indicate that the drug is effective against the new mutant version of the corona virus, Umaker.

The British pharmaceutical company GlaxoSmithclain (G.S.K.) announced today Thursday that its anti-Cofid-19 treatment is effective against the new mutant “Omaker.”

Laboratory tests, together with a study of hamster animals, showed that the combination of antibodies in their treatment of “Sutrophemab” was effective against viruses created through bioengineering that carried a number of mutations characteristic of the Omicron strain.

The two companies are developing so-called false viruses that carry the same major mutations in all the similar mutants that have emerged from the corona virus so far. The two companies are also conducting laboratory tests on the ability of Sutrovimap to influence it.

Reuters quoted Fair America’s chief scientific adviser, Herbert Wergin, as saying: “Every mutation that may be important is carefully pursued.”

He asserted that with the emergence of the new mutant, we found that the mutations we had tested so far had no significant effect on the Sutrovimap.

مقالات ذات صلة

زر الذهاب إلى الأعلى